Search EPC Resource Library Only
Search EPC Resource Library & ASN Site
Promoting Vaccine Confidence in the Pediatric Kidney Community
- Resource Categories: NTDS and Quality, Assessment, Improvement, Education.
ASN Project Firstline Education Modules
Building Blocks of Infection Prevention and Control 1 link
Infection Control in the Dialysis Settings 5 links
ASN Project Firstline Education Modules
- Resource Categories: Project Firstline.
More ASN Mentoring Resources
More ASN Mentoring Resources
- Resource Categories: FIND.
General Mentoring Resources
Elevator Pitch Resources 5 links
Microaggressions 3 links
Giving Feedback 1 link
Identity and Intersectionality 3 links
Leadership 2 links
General Mentoring Resources
- Resource Categories: FIND.
Mentee Resources
Resources for Mentees 2 links
Mentee Resources
- Resource Categories: FIND.
Mentor Resources
Early Mentoring 2 links
Mentoring Across Differences 5 links
- Mentoring Across Differences
- Thomas DA. The truth about mentoring minorities. Race matters. Harv Bus Rev. 2001 Apr;79(4):98-107, 168. PMID: 11299697.
- Lewellen-Williams, C. et al. The POD: A new model for mentoring underrepresented minority faculty. Acad Med 2006; 81-275-279.
- Bickel J. When "You're not the boss of me": Mentoring Across generational differences. In Mentoring: Program Development, Keel M. (ed), Nova Science Publishers Inc., 2009: 143-152.
- Maxwell, John. Mentoring 101: What Every Leader Needs to Know. Nashville: Thomas Nelson, 2008.
Sample Mentor/Mentee Agreements 3 links
Mentor Resources
- Resource Categories: FIND.
AKINow Journal Club Presentations
Intravenous Amino Acids for Kidney Protection 2 links
SOX9 switch activity determines healing with or without fibrosis after AKI 2 links
Teprasiran for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery 2 links
Automated medication-targeted alerts on AKI outcomes 3 links
Maladaptive proximal tubule cell dedifferentiation and renal fibrosis 2 links
AKINow Journal Club Presentations
- Resource Categories: AKINow.
Toolkit References and Resources
American Journal of Health-System Pharmacy 1 link
American Journal of Kidney Diseases (AJKD) 3 links
- Measurement and Estimation of GFR for Use in Clinical Practice: Core Curriculum 2021
- Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey
- Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate
Annals of Internal Medicine 1 link
Circulation 2 links
- Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
- Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
Clinical Biochemistry 1 link
Clinical Chemistry 3 links
- An Update on Reported Adoption of 2021 CKD-EPI Estimated Glomerular Filtration Rate Equations | Clinical Chemistry
- National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories
- Reporting Estimated Glomerular Filtration Rate (eGFR) for Adults | Chemistry Resource Committee
Clinical Journal of the American Society of Nephrology (CJASN) 1 link
Journal of the American Medical Association (JAMA) 1 link
Journal of the American Society of Nephrology (JASN) 3 links
- Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force
- A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
- What Does the American Heart Association Framework Mean for Nephrology?
Kidney360 1 link
Kidney International 2 links
National Kidney Foundation (NKF) 1 link
Nature Reviews Nephrology 1 link
The New England Journal of Medicine 2 links
Toolkit References and Resources
- Resource Categories: eGFR Resources.
Materials for Patient Education
National Kidney Foundation 4 links
UpToDate 1 link
Materials for Patient Education
- Resource Categories: eGFR Resources.
Clinical Tools
National Kidney Foundation (NKF) 6 links
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1 link
MDCalc 1 link
Kidney Failure Risk Equation 1 link
American Heart Association 1 link
Clinical Tools
- Resource Categories: eGFR Resources.
Clinical Guidelines
Kidney Disease Improving Global Outcomes (KDIGO) 2 links
Clinical Guidelines
- Resource Categories: eGFR Resources.
General Respiratory Illnesses Resources
Health Care Provider Resources 5 links
General Respiratory Illnesses Resources
- Resource Categories: KCVC.
Respiratory Syncytial Virus (RSV)
RSV General Information 2 links
Adult Reccomendations 3 links
Infants and Young Children Reccomendations 2 links
Respiratory Syncytial Virus (RSV)
Racial and Ethnic Disparities in Home Modalities
Racial and Ethnic Disparities in Home Modalities
- Resource Categories: Fostering Inclusivity in Dialysis Access.
Immunization Pocket Guide Information
Promoting Confidence in COVID-19 Vaccinations for People with Kidney Diseases 6 links
- Vaccination rates are very low -- very few dialysis patients in the U.S. are up to date with COVID-19 vaccines.
- Rates for morbidity and mortality are high: (1) About half of all people with kidney disease had a hospital stay in the first 30 days of a COVID-19 diagnosis and (2) People with kidney diseases were twice as likely (compared to people without kidney diseases) to die within 90 days of a COVID-19 diagnosis.
- COVID-19 poses unique risks to people with kidney diseases: (1) People on dialysis can have weaker immune systems, making it harder to fight infections and (2) People with kidney diseases are at higher risk for more serious COVID-19 illness.
- COVID-19 had a huge impact on the kidney patient population: An impact so significant (so many patients died) that for the first time in the 50-year history of the Medicare End-Stage Renal Disease program, the total number of people on dialysis in the United States declined.
- Many years of research led to the COVID-19 vaccines. The science behind the COVID-19 vaccines was NOT rushed. In fact, these vaccines were developed after decades of scientific research.
- All of the traditional steps for testing, evaluation, and review were completed thoroughly. Vaccine developers did not cut corners – they cut government “red tape.” Because the pandemic was a true global emergency, there was a worldwide effort to remove usual bureaucratic hurdles.
The Benefits of Being Vaccinated Against COVID-19 2 links
- Prevents serious illness: COVID-19 vaccines available in the United States are safe and effective at protecting people from becoming seriously ill, being hospitalized, and dying.
- A safer way to build protection: Receiving a COVID-19 vaccine is a more lasting way to build protection than immunity after being sick with a COVID-19 infection. Vaccine-induced immunity offers protection against severe illness for at least six months. Infection-induced immunity diminishes after 90-days.
Promoting Vaccines: Know Facts and Bust Myths 3 links
- Myth: "I had a COVID shot last year." -- Fact: The current vaccine formulation is different from previous years and must be used to fight this year’s COVID-19 variant.
- Myth: "I will get sick from the COVID shot." -- Fact: Acknowledge some people may experience mild side effects (i.e., soreness or minor swelling) and give assurance that the vaccine does not cause illness and does not contain a “live virus.
- Myth: "I feel healthy, so I don't have to worry." -- Fact: As a dialysis patient or a staff member of a facility, you may be more vulnerable to infections, hospitalizations, complications, or spreading COVID-19.
Immunization Pocket Guide Information
- Resource Categories: Immunization Tools and KCVC.